Purdue Takes Another Shot At Amneal Over OxyContin Generic
Purdue Pharma fired its latest salvo Tuesday in a bid to keep a generic version of pain medication OxyContin off the market, accusing Amneal Pharmaceuticals in a Delaware federal suit of...To view the full article, register now.
Already a subscriber? Click here to view full article